Vitamin D Modulates the Response of Bronchial Epithelial Cells Exposed to Cigarette Smoke Extract

In chronic obstructive pulmonary disease (COPD), the bronchial epithelium is the first immune barrier that is triggered by cigarette smoke. Although vitamin D (vitD) has proven anti-inflammatory and antimicrobial effects in alveolar macrophages, little is known about the direct role of vitD on cigar...

Full description

Saved in:
Bibliographic Details
Published inNutrients Vol. 11; no. 9; p. 2138
Main Authors Mathyssen, Carolien, Serré, Jef, Sacreas, Annelore, Everaerts, Stephanie, Maes, Karen, Verleden, Stijn, Verlinden, Lieve, Verstuyf, Annemieke, Pilette, Charles, Gayan-Ramirez, Ghislaine, Vanaudenaerde, Bart, Janssens, Wim
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 06.09.2019
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In chronic obstructive pulmonary disease (COPD), the bronchial epithelium is the first immune barrier that is triggered by cigarette smoke. Although vitamin D (vitD) has proven anti-inflammatory and antimicrobial effects in alveolar macrophages, little is known about the direct role of vitD on cigarette smoke-exposed bronchial epithelial cells. We examined the effects of vitD on a human bronchial epithelial cell line (16HBE) and on air-liquid culture of primary bronchial epithelial cells (PBEC) of COPD patients and controls exposed for 24 h to cigarette smoke extract (CSE). VitD decreased CSE-induced IL-8 secretion by 16HBE cells, but not by PBEC. VitD significantly increased the expression of the antimicrobial peptide cathelicidin in 16HBE and PBEC of both COPD subjects and controls. VitD did not affect epithelial to mesenchymal transition or epithelial MMP-9 expression and was not able to restore impaired wound healing by CSE in 16HBE cells. VitD increased the expression of its own catabolic enzyme CYP24A1 thereby maintaining its negative feedback. In conclusion, vitD supplementation may potentially reduce infectious exacerbations in COPD by the upregulation of cathelicidin in the bronchial epithelium.
ISSN:2072-6643
2072-6643
DOI:10.3390/nu11092138